BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37276927)

  • 21. Nucleophosmin in leukemia: Consequences of anchor loss.
    Brodská B; Šašinková M; Kuželová K
    Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
    Kazemi A; Safa M; Shahbazi A
    Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleolar stress characterized by downregulation of nucleophosmin: a novel cause of neuronal degeneration.
    Marquez-Lona EM; Tan Z; Schreiber SS
    Biochem Biophys Res Commun; 2012 Jan; 417(1):514-20. PubMed ID: 22166220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
    Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
    Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nucleophosmin mutations in hematological malignancies - review].
    Luo ZP; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.
    Li J; Zhang X; Sejas DP; Bagby GC; Pang Q
    J Biol Chem; 2004 Oct; 279(40):41275-9. PubMed ID: 15310764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells.
    Wojciechowski J; Horky M; Gueorguieva M; Węsierska-Gądek J
    Int J Cancer; 2003 Sep; 106(4):486-495. PubMed ID: 12845642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.
    Falini B; Bolli N; Shan J; Martelli MP; Liso A; Pucciarini A; Bigerna B; Pasqualucci L; Mannucci R; Rosati R; Gorello P; Diverio D; Roti G; Tiacci E; Cazzaniga G; Biondi A; Schnittger S; Haferlach T; Hiddemann W; Martelli MF; Gu W; Mecucci C; Nicoletti I
    Blood; 2006 Jun; 107(11):4514-23. PubMed ID: 16455950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygous
    Sheikh TI; Harripaul R; Vasli N; Ghadami M; Santangelo SL; Ayub M; Sasanfar R; Vincent JB
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
    Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
    J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
    Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
    Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
    Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
    Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
    Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
    J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
    Di Fiore PP
    J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.
    Secchiero P; Zerbinati C; di Iasio MG; Melloni E; Tiribelli M; Grill V; Zauli G
    Curr Drug Metab; 2007 May; 8(4):395-403. PubMed ID: 17504227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMH-21 inhibits viability and induces apoptosis by p53-dependent nucleolar stress responses in SKOV3 ovarian cancer cells.
    Fu X; Xu L; Qi L; Tian H; Yi D; Yu Y; Liu S; Li S; Xu Y; Wang C
    Oncol Rep; 2017 Aug; 38(2):859-865. PubMed ID: 28656213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
    Endo M; Nishioka T; Numazaki K; Hasegawa H; Takahashi T; Sugawara S; Tada H
    Anticancer Res; 2022 Jun; 42(6):2931-2937. PubMed ID: 35641264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA.
    Zhao CY; Grinkevich VV; Nikulenkov F; Bao W; Selivanova G
    Cell Cycle; 2010 May; 9(9):1847-55. PubMed ID: 20436301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
    Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
    Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.